The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merck
waveLINE-007: Phase 2 study of zilovertamab vedotin (ZV) in combination with cyclophosphamide, doxorubicin, and prednisone plus rituximab (R-CHP) in previously untreated diffuse large B-cell lymphoma (DLBCL).
 
David Lavie
Consulting or Advisory Role - Abbvie; BMS; Novartis; Roche; Takeda
 
Muhit Ozcan
Research Funding - Abbvie; Acerta Pharma/AstraZeneca; Bayer; Dr. Reddy's Laboratories; Janssen; Merck; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - Abbvie; Jazz Pharmaceuticals; Roche
 
Ewa Paszkiewicz-Kozik
Consulting or Advisory Role - Takeda
Speakers' Bureau - Abbvie; Roche; Takeda
Travel, Accommodations, Expenses - Roche
 
Eva González Barca
Consulting or Advisory Role - Abbvie; Beigene; EUSA Pharma; Gilead Sciences; Incyte; Janssen; Kyowa Kirin; Lilly O.; Takeda
Speakers' Bureau - Abbvie; Beigene; EUSA Pharma; Incyte; Janssen; Kyowa Kirin; Roche; Takeda
Travel, Accommodations, Expenses - Abbvie; EUSA Pharma; Janssen
 
Tae Min Kim
Consulting or Advisory Role - AstraZeneca/MedImmune; Janssen Oncology; Novartis; Regeneron; Samsung Bioepis; Takeda; Yuhan
Speakers' Bureau - IMBdx; Janssen Research & Development; Takeda
Research Funding - AstraZeneca
(OPTIONAL) Uncompensated Relationships - AstraZeneca/MedImmune; Boryung; Novartis; Roche/Genentech
 
Benedetta Puccini
No Relationships to Disclose
 
Siruo Wang
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Rushdia Yusuf
No Relationships to Disclose
 
Patricia Marinello
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Won Seog Kim
Research Funding - Beigene; Boryung; Dong-A Socio; Kyowa Kirin; Roche; Sanofi